Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Greene

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Medicinal Chemistry|August 16, 2011
Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastropheNiamh M O'Boyle, Miriam Carr, Lisa M Greene, et al.
Molecular Pharmacology|March 31, 2006
Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepinesJude M Mulligan, Lisa M Greene, Suzanne Cloonan, et al.
Biochemical Pharmacology|November 19, 2008
The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cellsSandra A Bright, Lisa M Greene, Tom F Greene, et al.
Journal of Medicinal Chemistry|April 21, 2017
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ ActivityNiamh M O'Boyle, Irene Barrett, Lisa M Greene, et al.
Oncology Reports|October 8, 2005
The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivoLisa M Greene, Marina Fleeton, Jude Mulligan, et al.
Journal of Medicinal Chemistry|December 19, 2015
Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor AgentsThomas F Greene, Shu Wang, Lisa M Greene, et al.
Cancer Research|October 15, 2009
The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemiaAnthony M McElligott, Elaina N Maginn, Lisa M Greene, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2010
The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistanceLisa M Greene, Seema M Nathwani, Sandra A Bright, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Medicinal Chemistry|August 16, 2011
Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastropheNiamh M O'Boyle, Miriam Carr, Lisa M Greene, et al.
Molecular Pharmacology|March 31, 2006
Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepinesJude M Mulligan, Lisa M Greene, Suzanne Cloonan, et al.
Biochemical Pharmacology|November 19, 2008
The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cellsSandra A Bright, Lisa M Greene, Tom F Greene, et al.
Journal of Medicinal Chemistry|April 21, 2017
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ ActivityNiamh M O'Boyle, Irene Barrett, Lisa M Greene, et al.
Oncology Reports|October 8, 2005
The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivoLisa M Greene, Marina Fleeton, Jude Mulligan, et al.
Journal of Medicinal Chemistry|December 19, 2015
Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor AgentsThomas F Greene, Shu Wang, Lisa M Greene, et al.
Cancer Research|October 15, 2009
The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemiaAnthony M McElligott, Elaina N Maginn, Lisa M Greene, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2010
The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistanceLisa M Greene, Seema M Nathwani, Sandra A Bright, et al.
Pageof 3